98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cpsurg.2024.101525 | DOI Listing |
BJS Open
September 2025
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Metastases in the lateral pelvic lymph nodes or mesenteric lymph nodes represent distinct categories of mid-low rectal cancer. This study investigated the patterns of mesenteric and lateral pelvic lymph node metastases in mid-low rectal cancer; the survival benefit of postoperative treatment was also analysed in these groups.
Methods: This retrospective multicentre study included consecutive patients with mid-low rectal cancer who underwent total mesorectal excision with lateral pelvic lymph node dissection in three Chinese institutions between 2012 and 2020.
J Pediatr Surg
September 2025
Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland; Department of Pediatric and Adolescent Endocrinology, University Children's Hospital of Krakow, Krakow, Poland.
Background: The primary goals of surgical management in thyroid disorders are the treatment of malignancy, goiter, and thyrotoxicosis, while adhering to the principle of 'primum non nocere'. Hypocalcemia is among the most common complications, primarily resulting from inadvertent injury to the parathyroid glands.
Methods: A retrospective analysis of 2015-2023 records of Polish pediatric patients who underwent thyroid surgery.
Ann Surg Oncol
September 2025
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Background: Lateral pelvic lymph node (LPLN) metastasis is a poor prognostic factor in rectal cancer, but the optimal management strategy is debated. This multicenter retrospective study investigated the role of LPLN dissection (LPLND), with total mesorectal excision (TME), after neoadjuvant chemoradiation therapy (nCRT), aiming to identify patients who may benefit from LPLND.
Patients And Methods: A total of 559 patients with locally advanced rectal cancer and LPLN involvement from 2009 to 2018 were included (KROG 22-09).
Front Endocrinol (Lausanne)
September 2025
Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
Background: Papillary thyroid carcinoma (PTC) frequently develops lateral lymph node metastasis (LLNM) in 12.6%-32.8% of patients, increasing recurrence risk and mortality.
View Article and Find Full Text PDFJ Gastrointest Surg
August 2025
Division of Colon and Rectal Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address:
Introduction: This study evaluates lateral lymph node (LLN) downstaging on restaging MRI and its impact on local recurrence (LR) in patients with stage III rectal cancer undergoing neoadjuvant therapy followed by curative surgery.
Methods: Retrospective review of adult patients with stage III rectal cancer who underwent neoadjuvant therapy followed by curative surgery between 2014 and 2023 at a high-volume center. Patients were divided into two groups based on LLN status: patients with negative LLN on baseline MRI (Group I) and patients with positive LLN on baseline MRI, which downstaged to negative on restaging MRI (Group II).